BIS Research ( Business Intelligence and Strategy Research)

  Rising economic burden of chronic diseases is considered to be one of the significant challenges that healthcare and biomedical research and development systems are facing at present. The high prevalence of chronic diseases, such as cancer, diabetes, cardiovascular diseases, and respiratory diseases, among others, is a prime concern across the globe. The chronic diseases have been responsible for 60% of the deaths worldwide and constitute approximately 43% of the global economic burden for diseases. According to World Health Organization in 2016, healthcare spending increased from 2.4% to 7.5% between 2015 and 2020.By 2020, the global spending on diseases, such as cardiovascular diseases, cancer, and respiratory diseases, is expected to reach $4 trillion. The chronic conditions hold approximately 65% of the annual healthcare cost of any country and one-third of the global population at present. Figure3: Chronic Conditions: Key Statistics Source: WHO Website, Deloitte 2016 Survey of U

The advent of batteries has facilitated the portability of several devices and limited the usage of wired connections. Lithium-ion battery was first invented by John Goodenough in 1980, and since its emergence, it has become an integral part of technological developments in various fields. Rechargeable lithium-ion batteries have brought a technological revolution in various applications starting from high-powered energy storage devices and electric buses to handheld electronic devices. Since the last 40 years of this innovation, lithium-ion batteries have been used in a varied range of products such as electric vehicles, mobile phones, laptops, and power tools. The staggering adoption of lithium-ion batteries portrays that it may continue being a prominent source of clean energy, at least till the next decade, especially in the electro mobility field. Thus, a huge dominance of lithium-ion batteries can be anticipated given the ongoing and anticipated trends. The surge in